Chronic Kidney Disease - REAL Life Study in Alsace

NCT05527626 | Recruiting

• 1 other identifier: 8517
• Study Type: observational
• Target: 3,000
• Locations: 1 country
• Sites: 1

Brief Summary

Chronic kidney disease (CKD) is a public health problem and affects about 10% of the world's adult population with a constantly increasing incidence. The approach to CKD in France is centered on access to replacement therapy (dialysis, renal transplantation), the cost of which amounts to 4 billion euros (data from the REIN registry). Real-life data are essential to specify the characteristics of patients with chronic kidney disease and the factors associated with the evolution of CKD and the occurrence of complications in order to improve the management of CKD before the suppletion stage. Since October 2019, CKD at the severe stage (stage 4) and at the non-dialysis end stage (stage 5) is subject to an annual flat fee (Article L. 162-22-6-2 of the Social Security Code). The reimbursement of these lump sums by the health insurance is subject to the collection and transmission of certain medical data by the establishments.

Conditions

Chronic Kidney Diseases

Keywords

Kidney; Chronic Disease; Chronic Kidney Disease

Outcome Measures

Primary Outcomes (1)

• Retroanalysis of the risk factors in patients with severe chronic kidney disease

  Analysis of risk factors in patients with severe chronic kidney disease by retrospectively analyzing health data contained in patient medical records

  Files analysed retrospectively from October 01, 2019 to February 31, 2027 will be examined

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Major subject (≥18 years) with a chronic renal disease

You may qualify if:

• Major subject (≥18 years)
• Subject included in the MRC package (GFR \<30 ml/min/1.73 m2)
• Subject who has not expressed opposition, after information, to the reuse of his or her data for the purpose of this research

You may not qualify if:

• \- Subject having expressed his opposition to participate in the study

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

Renal Insufficiency, Chronic; Chronic Disease

Condition Hierarchy (Ancestors)

Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Peggy PERRIN, MD

  Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Peggy PERRIN, MD

CONTACT

33 3 69 55 13 26; peggy.perrin@chru-strasbourg.fr

Saïd CHAYER, PhD, HDR

CONTACT

said.chayer@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 30, 2022
• First Posted: September 2, 2022
• Study Start: February 17, 2022
• Primary Completion (Estimated): August 1, 2027
• Study Completion (Estimated): August 1, 2027
• Last Updated: November 9, 2023

Record last verified: 2023-11

Locations

FR (1)